Nonadherence is common among high-risk patients initiating statins and is associated with suboptimal low-density lipoprotein cholesterol (LDL-C) reduction. LDL-C should be monitored to identify suboptimal response and medication nonadherence.
Michael E. Farkouh, MD, MSc
Advertisement
Articles by Michael E. Farkouh, MD, MSc
Advertisement
Latest Updated Articles
- LDL Cholesterol Response and Statin Adherence Among High-Risk Patients Initiating Treatment
Published: March 4th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
4
Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders
5
